Toru Hyodo

Prof. Toru Hyodo

Fureai Clinic Izumi

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2019 in Renal Replacement Therapy
Verified
Journal Article
Open access
PDF file
THToru Hyodo
Toru Hyodo
MFMasafumi Fukagawa
Masafumi Fukagawa
NHNobuhito Hirawa
Nobuhito Hirawa
MHMatsuhiko Hayashi
Matsuhiko Hayashi
KNKosaku Nitta
Kosaku Nitta
IWI. Gde Raka Widiana
I. Gde Raka Widiana
Since 2015, the Committee for International Communication on Academic Research of the Japanese Society for Dialysis Therapy has held its Asian symposium during the society’s Annual Congress to discuss the present status of and demand for dialysis therapy in Asian countries in order to identify needs and find ways to contribute to these countries in the area of dialysis therapy. Five manuscripts are presented here by symposium participants from Cambodia, Laos, Bhutan, Mongolia, and Indonesia from the Asian symposium of 2016. With progress in economic development, hemodialysis (HD) therapy has now been introduced in all countries worldwide. However, the cost of HD is extremely high compared with typical incomes in every country, and as of 2016, many countries still have not established national health insurance systems. In Cambodia and Laos, for example, patients must bear 100% of the cost for dialysis. In contrast, in Bhutan, the government bears all costs and the patients need not pay at all. In Mongolia and Indonesia, dialysis is almost completely covered by national health insurance. Dialyzers tend to be reused in Cambodia, Laos, and Indonesia. In Mongolia and Bhutan, dialyzers are single-use only. Continuous ambulatory peritoneal dialysis is available in Mongolia and Indonesia but is just starting to be introduced in Laos; it is not available in Cambodia and Bhutan. In Cambodia and Laos where there is no national health insurance system, patients with lower socioeconomic status come to the HD center only when they have enough money to pay for an HD session. Viable health insurance systems should be established as soon as possible. However, this will ultimately depend on the countries’ economic development.

14 December 2020 in Renal Replacement Therapy
Verified
Journal Article
Open access
PDF file
THToru Hyodo
Toru Hyodo
MFMasafumi Fukagawa
Masafumi Fukagawa
NHNobuhito Hirawa
Nobuhito Hirawa
YIYoshitaka Isaka
Yoshitaka Isaka
HNHidetomo Nakamoto
Hidetomo Nakamoto
CHChanseila Hy
Chanseila Hy
Since 2015, the Committee of International Communication on Academic Research of the Japanese Society for Dialysis Therapy has held its Asian symposium during the society's Annual Congress to discuss the present status of and demand for dialysis therapy in Asian countries. The aim of the symposium is to identify needs and find ways to contribute in the area of dialysis therapy in these countries. Three manuscripts are presented here by participants at the 2017 Asian symposium from Vietnam, Myanmar, and Cambodia. With economic development, hemodialysis (HD) therapy is now available worldwide. However, the cost of HD is very high compared with the average income in these three countries and, as of 2017, Cambodia and Myanmar have not yet established national health insurance systems. In Cambodia, patients must bear 100% of the cost for dialysis. In Myanmar, the government covers the cost of HD (20 USD, 40% of total cost) in public HD centers, but this service is still insufficient to meet current demand, with long waiting lists of up to 6 months at government HD centers. In contrast, in Vietnam, dialysis is almost completely covered by national health insurance. Dialyzers tend to be reused in all three countries. Continuous ambulatory peritoneal dialysis is available in Vietnam and Myanmar but not in Cambodia. Viable health insurance systems should be established as soon as possible in Cambodia and Myanmar, although this will ultimately depend on the countries' level of economic development.

6 January 2025 in Renal Replacement Therapy
Verified
Journal Article
Open access
PDF file
THToru Hyodo
Toru Hyodo
NHNobuhito Hirawa
Nobuhito Hirawa
TKTakahiro Kuragano
Takahiro Kuragano
YTYoshiaki Takemoto
Yoshiaki Takemoto
SUShunichiro Urabe
Shunichiro Urabe
IWI. Gde Raka Widiana
I. Gde Raka Widiana
In Japan, Mongolia, and Indonesia, dialysis care has been covered by national health insurance and social welfare programs as of 2022, which covers much of the cost burden. However, the proportion of this burden varies by country and Japan is the only one of these countries in which medical fees are fully covered for all dialysis patients. As systems for dialysis medical care coverage have been established, the number of dialysis patients has increased dramatically in each country. However, the cost of dialysis treatment itself is very high relative to personal income in all countries. This puts pressure on national healthcare budgets and gives rise to concerns about the sustainability of dialysis care in the future. Peritoneal dialysis (PD) is less expensive than hemodialysis (HD) in Mongolia and Indonesia, and a PD-first policy is considered effective in reducing costs. Nevertheless, an overwhelming number of patients still undergo HD. Despite the difficulties faced by these three countries in obtaining funds for dialysis treatment, among Asian countries, Mongolia and Indonesia are considered to have relatively advanced healthcare systems. It is considered that there has been progress in the provision of dialysis treatment subsidies to the citizens of these countries.

18 October 2022 in Renal Replacement Therapy
Verified
Journal Article
Open access
PDF file
THToru Hyodo
Toru Hyodo
AYAkihiro C. Yamashita
Akihiro C. Yamashita
NHNobuhito Hirawa
Nobuhito Hirawa
YIYoshitaka Isaka
Yoshitaka Isaka
HNHidetomo Nakamoto
Hidetomo Nakamoto
TSTakashi Shigematsu
Takashi Shigematsu
The present status of Cambodia, Myanmar, Laos, Vietnam, Mongolia, and Bhutan as of June 2019 was reviewed from the interviews of leading doctors in every country. The timing was until just 6 months before the COVID-19 pandemic broke out. The cost per hemodialysis session was 25–70 US dollar and expensive if it is compared with average monthly income of every country. In Cambodia and Laos, patients must cover 100% of expenses for maintenance hemodialysis, in Myanmar, the government covers the cost of once-weekly dialysis sessions, in Vietnam, the government covers 80% of the cost, and in Mongolia and Bhutan, the cost is fully covered by the government. Continuous ambulatory peritoneal dialysis was widely available in Vietnam and Mongolia, which have achieved a relative standard of social infrastructure, but is far from common in any of the other countries. The number of patients on dialysis is increasing with economic development in all countries. Diabetic nephropathy is a common primary reason for dialysis. None of the countries discussed in this article had clinical engineers who could maintain hemodialysis equipment and carry out clinical tasks in dialysis centers. Hospitals were not maintaining their equipment, and damaged units were kept in storage to be used for spare parts. None of the countries had dieticians to provide patients with dietary guidance. Establishment and training of both clinical engineers and registered dietitians are major projects that must be undertaken.

27 March 2019 in Journal of Artificial Organs
Verified
Journal Article
Closed access
PDF file
SUShunichiro Urabe
Shunichiro Urabe
THTakashi Hosono
Takashi Hosono
THToru Hyodo
Toru Hyodo
MKMakoto Kitamura
Makoto Kitamura
MHMiho Hida
Miho Hida
KKKenichi Kokubo
Kenichi Kokubo

16 May 2020 in Journal of Artificial Organs
Verified
Journal Article
Closed access
PDF file
SUShunichiro Urabe
Shunichiro Urabe
THToru Hyodo
Toru Hyodo
THTakashi Hosono
Takashi Hosono
YKYasuhisa Kurata
Yasuhisa Kurata
MKMakoto Kitamura
Makoto Kitamura
KKKenichi Kokubo
Kenichi Kokubo